centre hospitalier lyon sud;Service Hématologie

Pierre-Bénite, Rhône 69310

0 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia (CLL)

Studies at this site

• A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation — Completed